Monocyte chemotactic protein-3 (MCP-3), a chemokine that is in a superfamily of structurally related small chemotactic cytokines involved in leukocyte trafficking, is regarded as a key factor in atherogenesis. In this study, we examined the changes in atherogenic parameters including hepatic lipid accumulation and oxidative balance in MCP-3-overexpressing transgenic mice (MCP-3 mice) under atherogenic conditions. To induce an extreme atherogenic condition, mice were fed a high-fat, high-cholesterol (HFHC) diet for 12 weeks. The body weight and food intake were not changed by MCP-3 overexpression in the aorta. On a HFHC diet, the MCP-3 mice had higher plasma levels of total cholesterol and a higher atherogenic index compared with wild-type mice, although there were no differences in the plasma HDL-cholesterol and triglyceride levels. Furthermore, an increase in lipid accumulation was observed in the aortas as well as the livers of the HFHC diet-fed MCP-3 mice compared with wild-type mice. The activities of antioxidant enzymes increased in the livers of the HFHC diet-fed MCP-3 mice, whereas supplementation with antioxidants, naringin and hesperidin, reversed the activities of the hepatic antioxidant enzymes in HFHC diet-fed MCP-3 mice, indicating that there might be more oxidative damage to the tissues in the HFHC diet-fed MCP-3 mice leading to progression towards atherosclerosis and hepatic steatosis. Microarray analyses of the aorta revealed atherosclerosis-, PPARs-, lipoprotein receptor, and apolipoprotein-related genes that were affected by the HFHC diet in MCP-3 mice. These findings suggest that aortic MCP-3 overexpression may contribute to the development of atherosclerosis and hepatic steatosis under atherogenic conditions.
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Atherosclerosis is a complex disease characterized by excessive lipid accumulation and chronic inflammation in the vessel wall [34] . Higher levels of cholesterol in the blood are a well-known risk factor associated with the development of atherosclerosis. In particular, retention of low-density lipoproteins (LDL) and their subsequent oxidation lead to the formation of foam cells and fatty streaks in the vessel wall, which is the hallmark of the initiation of atherosclerosis [27] . Circulating monocytes are the precursor of foam cells, and there is evidence that oxidized LDL (ox-LDL) induces the expression of monocyte chemotactic protein (MCP)-1, which is involved in the recruitment of these monocytes into early atherosclerotic lesions [7] . MCP-1 was present in atherosclerotic lesions [24] , and overexpression of MCP-1 accelerated atherosclerosis [1] . On the contrary, deletion of MCP-1 in mice attenuated atherosclerosis [13, 14] , suggesting that MCP-1 expression is crucial for the development of atherosclerotic plaques.
MCP-3, another member of the CC chemokines, seems to have a similar role during atherogenesis. Studies conducted in our laboratory have shown that the expression of MCP-3 was up-regulated in both ox-LDL-treated human monocytic THP-1 cells and human atherosclerotic plaques [18] . We have also proposed a general mechanism for the delivery of pathogenic signals from oxidized LDL to specific atherogenic genes in which MCP-3 may be deeply involved in the delivery of the signal through PPARγ. A recent study revealed that MCP-3-deficient mice exhibited markedly reduced monocyte recruitment to inflammatory sites [32] . In addition, MCP-3 mRNA expression was significantly increased in the aortas of apolipoprotein E knockout (apoE KO) mice fed a high-fat, high-cholesterol (HFHC) diet [36] . However, compared with MCP-1, relatively little is known about the physiological roles of MCP-3.
Non-alcoholic fatty liver disease (NAFLD) can affect the progression of atherosclerosis [3] . In LDL receptor knockout (LDLR KO) mice and apoE KO mice, a widely used murine model of hypercholesterolemic atherosclerosis, NAFLD developed in conjunction with hypercholesterolemia and atherosclerosis [15, 31] . Patients with NAFLD had a markedly greater wall thickness of the carotid artery than those without NAFLD [4] . Furthermore, a recent study reported that hepatic steatosis, excessive lipid accumulation in the liver, was associated with atherosclerosis, independent of known metabolic and other common risk factors including visceral adiposity [6] . Although the biological mechanisms by which NAFLD could contribute to accelerate atherosclerosis are still poorly known, some possible mechanisms linking atherosclerosis and fatty liver are increased oxidative stress and dyslipidemia [3] .
In order to investigate the function of the MCP-3 in closer detail, transgenic mice in which MCP-3 is overexpressed in the vesicular endothelia were produced. In this study, we investigated the changes in the various atherogenic parameters in MCP-3-overexpressing transgenic mice on an atherogenic diet (HFHC diet), which has been used in the majority of murine atherosclerosis studies to promote hypercholesterolemia and atherosclerosis [12] .
MATERIALS AND METHODS

Transgenic Mice
The MCP-3 transgenic mice, derived from C57BL/6 mice, were obtained from Korea Research Institute of Bioscience and Biotechnology (KRIBB, Daejeon, Korea). The mice were bred, raised, and genotyped to verify the overexpression of MCP-3 and were between 6 to 8 weeks of age. Genotyping was performed by the PCR using MCP-3 cDNA specific primers. For PCR, extracted genomic DNA from a mouse tail was amplified using the forward primer 5'-ATGAGG ATCTCTGCCACGC-3' and the reverse primer 5'-TCAAGGTTT GGAGTTGGG-3' (Genotech, Daejeon, Korea). The amplified insert of the MCP-3 cDNA was analyzed on a 0.8% agarose gel containing ethidium bromide. On average, 80% of the mice properly overexpressed MCP-3 (Fig. 1A) .
Experimental Design
Normal C57BL/6 mice (8 weeks of age) were purchased as a control from Dae Han Biolink (DBL, Chung-buk, Korea) and maintained (A) PCR-amplified MCP-3 cDNA from transgenic mice depicted by genotyping. Total DNA extracted from the tail of a transgenic mouse was subjected to PCR amplification. Inserted cDNA (294 bp) was selectively amplified and visualized on the agarose gel. Lane C, genomic (wild-type C57BL/6 mice) MCP-3 gene; lane TG, MCP-3 cDNA from transgenic mice amplified by PCR. (B) Expressional patterns of MCP-3 in the iliac arteries. The arteries from the transgenic and wild-type mice were embedded in paraffin. Serial paraffin sections were used for immunological staining with an anti-serum against MCP-3. The avidin-biotin-horseradish peroxidase system was used for visualization. The brown-staining cells on the surface of the arteries in the sections represent positive signals specific for MCP-3. After staining, mouse arteries were counterstained with hematoxylin to visualize the general shape of the tissue. EC, endothelial cells; SMC, smooth muscle cells (magnification, ×400). (C) Atherosclerotic lesions in the sectioned aortas of wild-type and MCP-3 transgenic mice. Mice were fed a HFHC diet for 12 weeks. Arterial trees were perfused with 1× PBS. Using a stereomicroscope, the adventitial fat was dissected. Aortas were embedded in OCT (optimal cutting temperature) compound and stained with oil-red-O (magnification, ×400).
for 1 week on a normal lab-chow diet before the experiment. The MCP-3 transgenic mice and wild-type control mice were randomly divided into two groups, respectively. Thereafter, both MCP-3 transgenic mice and wild-type control mice were fed a normal diet (AIN-76 semi-purified diet) or a high-fat, high-cholesterol diet (HFHC; 1.25% of cholesterol, 15% of fat, and 0.5% of Na-cholate in AIN-76 semi-purified diet) for 12 weeks (normal diet-fed MCP-3 transgenic mice, n = 9; HFHC diet-fed MCP-3 transgenic mice, n = 13; normal diet-fed wild-type control mice, n = 10; HFHC diet-fed wild-type control mice, n = 10). In addition, the MCP-3 transgenic mice were fed a HFHC diet with 0.02% (w/w) naringin (Sigma-Aldrich, St. Louis, MO, USA) (HFHC-N) or 0.02% hesperidin (Sigma-Aldrich, St. Louis, MO, USA) (HFHC-H) for 12 weeks to evaluate antioxidant effects in the MCP-3 mice. The diet composition is shown in Table 1 . The mice were allowed free access to the food and water. Food intake and body weight were monitored daily. All procedures were approved by the animal ethics committee of Kyungpook National University.
Histological Analysis
The overexpressed MCP-3 on the mouse vesicular endothelium was analyzed by immunohistochemistry. The aorta from the iliac aorta to abdominal aorta and the descending thoracic aorta were extracted and fixed with phosphate-buffered formalin. The extracted aortas were embedded in paraffin and deparaffinized and rehydrated using xylene and ethanol, and were then incubated in 3% H 2 O 2 , boiled in 0.01 M citrate buffer for 10 min, and the sections then reacted with anti-MCP-3 serum as the primary antibody and biotinylated antirabbit immunoglobulin (LSAB kit; DAKO, Glostrup, Denmark) and stained with diaminobenzidine tetrahydrochloride / hematoxylin.
The livers were removed from the mice and fixed with phosphatebuffered formalin. All fixed tissues were processed routinely for paraffin embedding, and 4 µm sections were prepared and stained with hematoxylin eosin (H&E). Stained areas were viewed using an optical microscope (Zeiss Axioscope; Munich, Germany) with a magnifying power of ×400.
Blood Collection and Plasma Lipids
Blood was collected from mice that had been fasted for 4 h prior to the collection from the tail vein at 1, 4, 8, and 12 weeks after an experimental diet, to measure the plasma levels of cholesterol and triglyceride. After 12 weeks on the diet, the mice were fasted for 12 h and blood samples were taken from the inferior vena cava to determine the plasma biomarkers. Plasma total cholesterol (TC) [2] , HDL-cholesterol (HDL-C) [33] , and triglyceride [5] concentrations were measured using enzymatic kits (Asan Pharm., Seoul, Korea).
Antioxidant Enzyme Activities
The superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), and glucose-6-phosphate dehydrogenase (G6PD) activities were measured as previously described [19] .
Analysis of Gene Expression Profiles in the Mouse Artery
Total RNA was extracted from mice arteries using Trizol reagent (Promega). A microarray was performed with the GenePlorer Mouse-14K DNA chip by Digital Genomics (Seoul, Korea). The DNA chip data were corrected by intensity/location-dependent normalization [35] .
Statistical Analysis
The data were expressed as the means ± SE. One-way analysis of variance (ANOVA) was used to compare significant differences among the groups using SPSS according to Duncan's multiple-range test, if differences were identified between the groups at a level of p < 0.05.
RESULTS AND DISCUSSION
Verification of Overexpressed MCP-3 in Transgenic Mice
In the genotyping of the transgenic mice overexpressing MCP-3 (MCP-3 mouse) using PCR, a MCP-3 cDNA band (294 bp) was clearly visualized on the agarose gel (Fig. 1A , lane TG). In the iliac artery, the expression level of MCP-3 was higher in the MCP-3 mice than in the wild-type mice in the immunostaining experiments (Fig. 1B) . When atherosclerotic lesions in the sectioned aortas were stained with oil-red-O, a heavier staining was observed in the sections of the HFHC-fed MCP-3 mice than that of the HFHC-fed wild-type mice (Fig. 1C) . These findings indicate that the transgenic mice used in this study not only overexpress MCP-3 but also are suitable to investigate the functions of MCP-3 in the process of atherogenesis.
Body Weight Gain and Food Intake
There were no differences in body weight gain and average daily food intake during the experimental period (12 weeks) between the MCP-3 mice and wild-type mice (Table 2) .
However, body weight gain as well as average daily food intake was significantly lower in the HFHC-fed groups than in the normal diet-fed groups. The rate of body weight gain was different only between the diet group, regardless of the genotype ( Fig. 2A) . The increase in rate stopped at the 6 th week in both the MCP-3 and wild-type mice on the HFHC diet, whereas the rate continued to increase until the Food intake (g/day) 2.9 ± 0.07 Mean ± SE. MCP-3 mice on a HFHC diet (n = 13), MCP-3 mice on a normal diet (n = 9), wild-type mice on a HFHC or normal diet (n = 10, respectively).
abc Means in the same row not sharing a common superscript are significantly different between the groups at p < 0.05. Normal: AIN-76 semi-purified diet; HFHC: a high-fat, high-cholesterol diet based on the AIN-76 semi-purified diet; HTR (ratio of HDL-cholesterol/total cholesterol): (HDL-cholesterol/total cholesterol)×100. Fig. 2 . Changes in the body growth rate (A), plasma cholesterol concentrations (B, C), and atherogenic index (D) of the wild-type and MCP-3 mice fed a normal or HFHC diet.
-• -, MCP-3 mice on a HFHC diet; -■-, MCP-3 mice on a normal diet; -▲ -, wild-type mice on a HFHC diet; -× -, wild-type mice on a normal diet. The experimental diet was started on the 6 th week and continued until the 12 th week. Body weight was measured a week after the diet was started. The means are normalized with the 1-week values in each group. end of the experimental period in the normal diet groups. This might be due to a low preference for the HFHC diet in the animals or to the high content of carbohydrates in the normal diet compared with the HFHC diet. A recent study revealed that a high carbohydrate diet (75% carbohydrates, 5% fat, as a percentage of the total calories) increased body weight and body fat compared with a low carbohydrate diet (35% carbohydrates, 45% fat, as a percentage of the total calories) by regulating the expression of genes involved in glucose transport, glycolysis, fatty acid and triglyceride biosynthesis, desaturation and elongation, adipogenesis, and adipokines [29] .
Plasma Lipids and Hepatic Droplets Levels
There was a significant difference in the plasma total cholesterol concentration between the genotypes as well as between the different diets (Fig. 2B) . The HFHC diet induced a significant increase in the plasma total cholesterol concentrations compared with the normal diet in both the MCP-3 and wild-type mice. In particular, the plasma total cholesterol concentrations in the HFHC diet-fed MCP-3 mice were significantly higher than in the wild-type mice on the same diet. When we compared the changes in plasma total cholesterol concentrations during the experimental period, the plasma total cholesterol concentrations in the wild-type mice increased until 4 weeks and 8 weeks on the HFHC and normal diets, respectively, and decreased drastically thereafter (Fig. 2C) . In contrast, the plasma total cholesterol concentrations increased constantly until the end of the experimental period in the MCP-3 mice on both diets. There were no differences in the plasma HDLcholesterol concentrations between the MCP-3 and wildtype mice fed the HFHC diet (Table 2 ). However, in addition to the high plasma cholesterol concentrations in the MCP-3 mice, the AI values of the MCP-3 mice were significantly higher than those of the wild-type mice on a HFHC diet (Fig. 2D) , suggesting that overexpression of MCP-3 might accelerate the progression of atherosclerosis on a HFHC diet. On the other hand, HDL-cholesterol levels as well as the HTR values in the normal diet-fed MCP-3 mice were significantly higher than those of the wild-type mice on the same diet, although there were no significant differences in the AI values between the two groups ( Table 2 and Fig. 2D ). These findings suggest that MCP-3 may sensitively respond to a HFHC diet towards atherogenesis under the experimental conditions.
In contrast to the plasma total cholesterol concentrations, plasma triglyceride levels in the HFHC diet-fed mice were lower than in those fed on the normal diet, irrespectively of the genotypes (Table 2 ). These findings might be due to the relatively low carbohydrate content in the HFHC diet compared with the normal diet, since a high carbohydrate diet increased hepatic de novo lipogenesis, steatosis, and very low-density lipoprotein secretion, resulting in higher serum triglyceride accumulation [25] . Similarly, a recent study reported that the HFHC diet significantly increased the plasma total cholesterol levels in apoE KO and wildtype C57BL/6J mice compared with a normal diet, but decreased the plasma triglyceride levels in both mice [10] . Furthermore, the HFHC diet that included cholate [40% fat, 1.25% cholesterol, 0.5% cholate (w/w)] significantly increased the serum cholesterol levels in LDLR KO mice compared with those fed a HFHC diet without cholate [40% fat, 1.25% cholesterol (w/w)], whereas the addition of cholate in the HFHC diet led to decreased plasma triglyceride levels [20] , suggesting that cholate can decrease plasma triglyceride levels.
Consistent with the plasma total cholesterol concentrations, pronounced diet-and genotype-specific differences were observed in the hepatic lipid droplets (Fig. 3) . When the liver tissues were subjected to H&E staining in order to visualize the lipid accumulation in the liver, hepatic lipid accumulation was significantly higher in the mice fed the HFHC diet than those fed the normal diet. In particular, a Fig. 3 . Changes in the liver morphology in wild-type and MCP-3 transgenic mice fed a HFHC or normal diet for 12 weeks.
Wild-type and MCP-3 mice were fed a normal or HFHC diet for 12 weeks, respectively. The livers were removed from the mice and fixed with phosphate-buffered formalin. All fixed tissues were processed routinely for paraffin embedding, and 4 µm sections were prepared for staining with hematoxylin & eosin (H&E). Stained areas were viewed using an optical microscope (Zeiss Axioscope, Munich, Germany) with a magnifying power of ×400. Representative H&E-stained images are shown. large amount of lipid droplets was observed in the livers from the HFHC diet-fed MCP-3 mice compared with the wild-type mice on the same diet. These findings indicate that an overexpression of MCP-3 in the aorta induces hypercholesterolemia and promotes cholesterol accumulation in the liver as well as the aorta.
Hepatic Antioxidant Enzyme Activities
The activities of hepatic SOD, an enzyme converting superoxide (O 2-) to hydrogen peroxide (H 2 O 2 ), was generally higher in the HFHC diet-fed mice, especially in the HFHC diet-fed MCP-3 mice (Table 3 ). Since the enzyme has been known to function in the early stage of free radical formation, it appears that an excessive amount of oxygen free radical generated in the HFHC diet-fed MCP-3 mice makes the liver more sensitive to the production of oxygen radicals. The activities of hepatic CAT, an enzyme converting H 2 O 2 to water and oxygen, were significantly higher only in the HFHC diet-fed mice, regardless of the genotypes. The activities of GPX, which reduces both H 2 O 2 and lipid peroxides simultaneously, increased significantly only in the HFHC diet-fed MCP-3 mice. A similar experiment with erythrocytes from the HFHC diet-fed MCP-3 mice showed a significantly lower GPX activity compared with the wild-type mice on the same diet (data not shown). A tissue-specific increase in the GPX activity in the liver may support the influence of the HFHC diet on oxidative stress in the MCP-3 mice. The activities of both GR, a glutathione reducing enzyme using NADPH, and G6PD, an NADPH supplying enzyme, also increased significantly only in the HFHC diet-fed MCP-3 mice. In addition, the concentrations of glutathione in the hepatic tissues were significantly high in the MCP-3 mice compared with the wild-type mice. Hepatic antioxidant enzymes have been recognized to be closely associated with liver damage and atherosclerosis caused by oxygen radicals [9, 17, 30] . According to the results in this study, the MCP-3 mice seemed to be more sensitive to the atherogenic diet and more vulnerable to oxidative stress and further progression of atherosclerosis.
Effects of Naringin and Hesperidin in MCP-3 Mice
Supplementation of naringin and hesperidin, representative flavonoids found in the skin of oranges, in the HFHC diet did not alter the plasma triglyceride levels in the MCP-3 transgenic mice. However, hesperidin resulted in a significant decrease in total cholesterol and an increase in the plasma HDL-cholesterol. Naringin also significantly increased the plasma HDL-cholesterol levels in the MCP-3 transgenic mice, although there was no significant change in the plasma total cholesterol level (Table 3) . Extremely high levels of HDL-cholesterol in the normal diet-fed MCP-3 mice, a characteristic lipid profile of MCP-3 mice, were observed when supplemental flavonoids were added to the HFHC diet. A corresponding decrease in the AI was also observed in the flavonoid-supplemented group. Accordingly, the atherogenic character of the MCP-3 mice represented by the decrease in the HDL-cholesterol in the HFHC dietfed MCP-3 mice, shown in Table 2 , was completely recovered by supplementation with flavonoids. In addition, the activities of the antioxidant enzymes, SOD, GPX, and G6PD, generally decreased in the livers of the MCP-3 mice fed a HFHC diet supplemented with flavonoids, representing the buffering effects of the flavonoids against oxidative damages caused by the HFHC diet.
Expression of Atherosclerosis-Related Genes in MCP-3 Mice
Genes differentially expressed in the HFHC or normal dietfed MCP-3 mice were identified by microarray analyses [28] . Expression patterns were monitored using RNA chips (Mouse-14K, manufactured by Digital Genomics, Seoul, Korea). Overexpressed genes from the microarray analyses were recorded in the MA plot, which presents two values: the A-value representing the signal intensity and the M-value representing the differences in gene expression Mean ± SE. MCP-3 mice on a HFHC diet (n = 13), MCP-3 mice on a normal diet (n = 9), wild-type mice on a HFHC or normal diet (n = 10, respectively).
abc Means in the same row not sharing a common superscript are significantly different between the groups at p < 0.05. Normal: AIN-76 semi-purified diet; HFHC: a high-fat, high-cholesterol diet based on the AIN-76 semi-purified diet; SOD: superoxide dismutase; CAT: catalase; GPX: glutathione peroxidase; GR: glutathione reductase; G6PD: glucose-6-phosphate dehydrogenase; GSH conc.: glutathione concentration. [8] . The bigger the values are, the more different they are. As shown in Fig. 4A , the dots in the boxes represent genes with a relatively large difference in their expressions between the HFHC and the normal diet-fed MCP-3 mice. Overexpressed genes, compared with those expressed in the normal diet-fed MCP-3 mice, were selected from the following categories (Fig. 4B): 1 ) genes known to be involved in the formation of atherosclerotic plaques, 2) genes involved in the field of peroxisome proliferatoractivated receptors (PPARs), 3) genes related to the LDL receptor, and 4) genes related to lipoprotein metabolism. We decided to look into those genes because there have been many evidences and implications in the literature that those genes might be important in the process of the atherogenesis. In the formation of atherosclerotic plaques, selectin, a gene involved in the adhesion of monocytes to the blood vessel endothelia in the early stage of atherogenesis, was identified as been overexpressed in the MCP-3 mice on the HFHC diet. The gene coding for scavenger receptor class B in macrophages, a protein playing an important role in the excretion of cholesterol from the body through reverse-cholesterol transport, was overexpressed in the MCP-3 mice on the normal diet. This result was well correlated with their elevated HDLcholesterol level shown in Table 2 . Together with the extremely low level of HDL-cholesterol on an HFHC diet, the results suggest that the MCP-3 appears to respond sensitively to the HFHC diet and has a role in the formation of atherosclerotic plaques in mice on a HFHC diet. Expression of PPARs in the MCP-3 mice generally increased on the normal diet, and only PPARγ increased on the HFHC diet. It has been shown that the expression level of PPARγ was elevated, as well as class A scavenger receptor and CD36, in atherosclerotic plaques, presumably by the influence of oxidized LDL [23, 26] . Since the PPARs follow many different mechanisms depending upon the ligands bound to the receptor, it is hard to generalize their actions in the MCP-3 mice under different diets. However, it seems to be clear that PPARγ of monocytes or macrophages in MCP-3 mice suppresses the expression of inducible nitric oxide synthase, scavenger receptor A, and several proinflammatory cytokines such as tumor necrosis factor-α, interleukin-6, and interleukin-1β, as shown previously [11, 16, 21, 22] . For LDL receptorrelated genes, which decide the content of steroids in the cells, a 30-50% increase in the activity of LDL receptors in the MCP-3 mice on the normal diet appeared to be important. This suggests that the overexpression of MCP-3 may lead to an increased uptake of cholesterol into the cells, or oxidized LDL in the case of the MCP-3 mice on the HFHC diet. For the apolipoprotein genes, the apo-AI gene was up-regulated in the MCP-3 mice on the normal diet, which is well correlated with the elevated HDL- (A) MA scatter plot for global normalization of the data obtained from the microarray analyses. A commercially available cDNA chip (Digital Genomics, Seoul, Korea; GenePlorer Mouse-14K) was used. In a typical microarray experiment, the RNAs from MCP-3 mice fed a HFHC or normal diet were differently labeled (Cy5 and Cy3, respectively). After the probes were allowed to hybridize with the pre-mounted cDNAs on the microchip, the hybridized cDNAs showed a positive signal as a specific color (fluorescent or phosphorescent colors) and the expression levels were expressed as the strength of the overlapped images originating from the two dyes. These signals are necessary so that they can be transformed to normalize the data according to the strength of the signals. The intensity/location-dependent normalization method (Yang et al. [35] ) was used to normalize the chip data. Dots in the figure represent individual cDNAs hybridized with a specific probe and a dot close to the line M = 0 means no or little difference between the two signals, indicating that there is not much difference in the expression of a gene. The horizontal axis (A value) represents the signal intensity, and the vertical axis (M value) represents the differences in the expression of a corresponding gene. The M = 0 line means that R equals G; M = log2(R/G); A = {log2(R×G)}/2; R = Cy5 signal-background, G = Cy3 signal-background. The dots in the boxes show large differences in their expression. (B) Relative expression patterns of genes most-probably-related to atherogenesis in the transgenic mice overexpressing MCP-3. Genes were selected according to the following criteria after allowing the cDNAs on the chip to interact with the total RNAs obtained from the MCP-3 mice fed a normal or HFHC diet: 1) the genes were consistently up-regulated in the microarray when hybridized with the total RNAs; 2) those genes considered to be important in the area of atherosclerotic lesion formation; 3) those genes considered to be related to PPARs; 4) those genes considered to be related to the LDL receptor; and 5) those genes considered to be related to apolipoproteins. The left side from the central bar means "up-regulated" when the MCP-3 mice were fed a normal diet, and the right side means "up-regulated" when the MCP-3 mice were fed a HFHC diet.
cholesterol in the MCP-3 mice on the normal diet. As expected, an elevated apo-B expression was observed in the mice on the HFHC diet.
In conclusion, overexpression of MCP-3 in the aorta increased plasma total cholesterol, atherosclerotic lesions, and hepatic lipid accumulation under atherogenic condition, suggesting that aortic MCP-3 is involved in the development of atherogenesis and related diseases such as hepatic steatosis. Although these changes were related to various aortic genes involved in the formation of atherosclerotic plaques, PPARs, LDL receptor, and lipoprotein metabolism as well as the hepatic oxidative status, further studies are needed to elucidate the detailed mechanisms underlying aortic and hepatic lipid accumulation in HFHC diet-fed MCP-3-overexpressing transgenic mice.
